Diller L, Kassel J, Nelson C E, Gryka M A, Litwak G, Gebhardt M, Bressac B, Ozturk M, Baker S J, Vogelstein B
Massachusetts General Hospital Cancer Center, Charlestown 02129.
Mol Cell Biol. 1990 Nov;10(11):5772-81. doi: 10.1128/mcb.10.11.5772-5781.1990.
Mutations in the p53 gene have been associated with a wide range of human tumors, including osteosarcomas. Although it has been shown that wild-type p53 can block the ability of E1a and ras to cotransform primary rodent cells, it is poorly understood why inactivation of the p53 gene is important for tumor formation. We show that overexpression of the gene encoding wild-type p53 blocks the growth of osteosarcoma cells. The growth arrest was determined to be due to an inability of the transfected cells to progress into S phase. This suggests that the role of the p53 gene as an antioncogene may be in controlling the cell cycle in a fashion analogous to the check-point control genes in Saccharomyces cerevisiae.
p53基因的突变与多种人类肿瘤相关,包括骨肉瘤。尽管已经表明野生型p53能够阻断E1a和ras共同转化原代啮齿动物细胞的能力,但对于p53基因失活为何对肿瘤形成很重要却知之甚少。我们发现,编码野生型p53的基因过表达会阻断骨肉瘤细胞的生长。经确定,生长停滞是由于转染细胞无法进入S期所致。这表明,p53基因作为一种抗癌基因,其作用可能是以类似于酿酒酵母中检验点控制基因的方式来调控细胞周期。